New Challenge to Cancer and Longevity
November 2022
in “
CARDIOMETRY
”
Studysummary This article discusses the potential benefits of GcMAF and oral MAF, developed by "Saisei Mirai", for cancer and other conditions, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
"Saisei Mirai," a group focusing on cancer treatments, has developed immunotherapies such as GcMAF and oral MAF, which have shown promising effects not only for cancer but also for a range of other conditions including infectious diseases, autism spectrum disorder (ASD), chronic fatigue syndrome (CFS), atopic dermatitis, hair loss, multiple sclerosis, and autoimmune diseases. They are collaborating with 6 universities in Japan to further improve these treatments. The document appears to be an introduction to a more detailed discussion on their cancer treatments.
